Biotechnology Stocks
| # | Last 7 Days | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 117 | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 502.31 USD | -0.24% | -4.83% | -4.92% | +22.24% | 127.32 B USD | ||
| 217 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 738.72 USD | +1.62% | -1.48% | -9.29% | +26.49% | 76.05 B USD | ||
| 223 | MRNA Moderna, Inc. - Common Stock | 187.46 USD | -7.75% | +0.49% | +28.64% | +584.41% | 74.84 B USD | ||
| 285 | ARGX argenx SE - American Depositary Shares | 930.52 USD | +1.93% | -4.08% | -7.34% | +16.22% | 57.58 B USD | ||
| 355 | RVMD Revolution Medicines, Inc. - Common Stock | 199.87 USD | -3.76% | -2.73% | -3.94% | +260.78% | 42.84 B USD | ||
| 443 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 223.94 USD | +1.84% | -11.72% | -13.78% | -51.78% | 29.97 B USD | ||
| 493 | ROIV Roivant Sciences Ltd. - Common Shares | 35.53 USD | -0.70% | -3.03% | -11.17% | +94.05% | 25.66 B USD | ||
| 504 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.44 USD | -0.39% | -3.04% | -4.68% | +51.48% | 25.20 B USD | ||
| 528 | UTHR United Therapeutics Corporation - Common Stock | 541.62 USD | +0.97% | +12.32% | +9.75% | +18.64% | 23.23 B USD | ||
| 532 | INSM Insmed Incorporated - Common Stock | 105.23 USD | +1.35% | -9.01% | -15.67% | -35.06% | 22.98 B USD | ||
| 533 | BNTX BioNTech SE - American Depositary Shares | 95.73 USD | -1.96% | -2.32% | -4.50% | -10.24% | 22.97 B USD | ||
| 537 | INCY Incyte Corporation - Common Stock | 112.73 USD | -1.23% | -8.53% | -9.17% | +30.23% | 22.85 B USD | ||
| 677 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 231.39 USD | -1.97% | -1.04% | -3.59% | +65.28% | 15.02 B USD | ||
| 703 | EXEL Exelixis, Inc. - Common Stock | 58.33 USD | -0.88% | -1.47% | -1.09% | +49.41% | 14.45 B USD | ||
| 712 | ASND Ascendis Pharma A/S - American Depositary Shares | 226.05 USD | -0.87% | -0.84% | -14.14% | +10.23% | 14.01 B USD | ||
| 721 | SMMT Summit Therapeutics Inc. - Common Stock | 17.31 USD | +0.23% | +4.21% | -0.69% | -12.84% | 13.81 B USD | ||
| 750 | BBIO BridgeBio Pharma, Inc. - Common Stock | 66.96 USD | +1.24% | +1.24% | -9.02% | +17.47% | 13.09 B USD | ||
| 758 | CORT Corcept Therapeutics Incorporated - Common Stock | 119.57 USD | -2.02% | +4.16% | +9.83% | +62.97% | 12.93 B USD | ||
| 786 | HALO Halozyme Therapeutics, Inc. - Common Stock | 109.72 USD | +1.30% | -1.63% | +0.66% | +64.25% | 12.45 B USD | ||
| 823 | MDGL Madrigal Pharmaceuticals, Inc. - Common Stock | 496.45 USD | +0.57% | -3.24% | -7.06% | +17.20% | 11.47 B USD |
News Biotechnology Stocks
Caribou Biosciences (CRBU) Shares Fall 35% After Hours: Here's Why
Ocular Therapeutix, Inc. (OCUL) Presents at Euretina 2026 - Slideshow (NASDAQ:OCUL) 2026-10-06
As Microsoft Adapted To AI Megatrend, Sales, Profits Surged. MSFT Leads 9 Joining IBD Best Stock Lists
OmniAb, Inc. (OABI) Analyst/Investor Day Transcript
ArriVent BioPharma: Phase 3 Failure Resets The Investment Case (Rating Downgrade)
12 Health Care Stocks Moving In Tuesday's After-Market Session
Humacyte, Inc. (HUMA) Stock Slides as Market Rises: Facts to Know Before You Trade
Gainers Biotechnology Stocks
CINGW Cingulate Inc. - Warrants | 0.0065 | +91.18% |
CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1300 | +24.52% |
JAGX Jaguar Health, Inc. - Common Stock | 5.62 | +18.82% |
JUNS Jupiter Neurosciences, Inc. - Common Stock | 2.86 | +18.18% |
LEXX Lexaria Bioscience Corp. - Common Stock | 3.24 | +16.97% |
CVM Cel-Sci Corporation Common Stock | 2.70 | +13.45% |
BCTXZ BriaCell Therapeutics Corp. - Warrant | 0.2800 | +12.86% |
NXTC NextCure, Inc. - Common Stock | 5.69 | +12.67% |
Losers Biotechnology Stocks
AVBP ArriVent BioPharma, Inc. - Common Stock | 15.09 | -46.98% |
SXTP 60 Degrees Pharmaceuticals, Inc. - Common Stock | 1.11 | -22.92% |
DNA Ginkgo Bioworks Holdings, Inc. Class A Common Stock | 12.41 | -17.16% |
ERNA Ernexa Therapeutics Inc. - Common Stock | 2.24 | -17.04% |
VRAX Virax Biolabs Group Limited - Ordinary Shares | 2.03 | -15.42% |
YDESW YD Bio Limited - Warrants | 0.5300 | -14.52% |
AGEN Agenus Inc. - Common Stock | 7.49 | -14.20% |
SYRE Spyre Therapeutics, Inc. - Common Stock | 80.11 | -13.60% |